A man living with a rare and degenerative disorder is making a heartfelt plea to officials to get approved for a treatment that will help to prevent further damage to his lungs and liver. Alpha-1 Antitrypsin Deficiency is a disorder caused by a missing blood enzyme that leads to liverContinue Reading
The COVID-19 pandemic is a global emergency. Identifying populations who are at risk of severe complications is crucial in developing special measures to prevent or reduce severe illness and mortality in vulnerable patients. Emerging evidence indicates that alpha1-proteinase inhibitor might inhibit infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). α1-AntitrypsinContinue Reading
18th October 2020 Professor Gerry McElvaney (left), the study’s senior author and a consultant in Beaumont Hospital, and Professor Ger Curley (right) stand in front of the RCSI Education and Research Centre in Beaumont Hospital, Dublin. Scientists have developed, for the first time, a score that can accurately predictContinue Reading
On Tuesday 20 October, the BBC documentary Surgeons: At the edge of life will show David (pictured below) receiving a double lung transplant. David received his new lungs earlier this year at the Royal Papworth Hospital, Cambridge. The show airs on BBC2 at 21:00 on the 20th October 2020. InContinue Reading
RESEARCH TRIANGLE PARK — Grifols, a global biotherapeutics company, has begun Phase 3 clinical trials in patients with COVID-19 with its therapeutic manufactured in Clayton. The Spanish company is testing its hyperimmune globulin for its safety, effectiveness and tolerability as a weapon to combat SARS-CoV-2, the virus that causes COVID-19. SinceContinue Reading
Tel Aviv University researchers suggest that carriers of the genetic mutations PiZ and PiS are at high risk for severe illness and even death from COVID-19. These mutations lead to deficiency in the alpha1-antitrypsin protein, which protects lung tissues from damage in case of severe infections. Other studies have alreadyContinue Reading
RICHLAND, WA- The Wishing Star Foundation is a non-profit based out of Spokane that grants the wishes of children ages 3-21 with terminal, life threatening or medically complicated conditions. Friday the non-profit granted the wish of a young Richland girl named Oaklee McBride. Oaklee has Alpha-1 Antitrypsin Deficiency an inherited condition thatContinue Reading
Researchers in Ireland are hoping to add to the growing list of drug candidates for the treatment of patients with severe Covid-19 infection. A team from the Royal College of Surgeons in Ireland (RCSI) has published a paper in the American Journal of Respiratory and Critical Care Medicine describing a promising therapyContinue Reading
MOUNT PLEASANT (WJRT) (4/21/2020) – At 37, Paul DeWyse was diagnosed with a rare disease called alpha 1 antitrypsin deficiency. “Basically that is your liver doesn’t produce antitrypsin to go up to protect your lungs. It’s a fatal disease unless the only cure is a lung transplant,” said DeWyse. About 20Continue Reading
[Warning: The below contains MAJOR spoilers for Season 16, Episode 15 of Grey’s Anatomy, “Snowblind.”] The blizzard isn’t the only disaster in this Grey’s Anatomy episode—Season 16, Episode 15 Hayes’ patient this week is Elisa, a 6-year-old with alpha-1 antitrypsin deficiency—the same disorder that killed her older sister, one of Alex’s patients. ElisaContinue Reading
